Yazar "Uysal, S." seçeneğine göre listele

Listeleniyor 1 - 2 / 2
  • Küçük Resim Yok
    Öğe
    The effect of non-ionizing radiation on the ovarian reserves of female rats
    (Imr Press, 2017) Yuvaci, H. U.; Uysal, S.; Haltas, H.; Sirav, B.; Duvan, C. I.; Turhan, N.; Seyhan, N.
    Objective: The authors aimed to investigate whether there was any effect of 1800 MHz GSM-modulated radio frequency radiation (RFR) as a source of non-ionizing radiation on the ovarian reserves of female rats by hematoxylin eosin staining under a light microscope, and also to evaluate the effect on the anti-Mulllerian hormone (AMH) level of rats. Design: A prospective observational study. Materials and Methods: A total of 12 age-matched young adult female Wistar albino rats were divided into two groups. Group 1 (n=6) constituted the controls; group 2 (n=6) constituted the 1800 MHz exposed animals. RFR exposed group were kept ten cm away from the horn antenna to satisfy the near field condition. The control group was kept in the same setting without any RFR exposure. The exposure period was 20 minutes for five days/week for one month. Results: The results of this study showed that 1800 MHz RFR did not have a significant effect on the ratios of atretic follicles in rat ovary tissues when compared with the control group (p>0.05). However, the authors detected statistically significantly higher AMH levels in RFR exposed groups (p<0.005). Conclusions: 1800 MHz GSM modulated RFR exposure in rats was found to have no adverse effect on ovarian reserves or follicles. The present authors' failure to detect any changes could be due to the limited duration of the RFR exposure or the limited number of subjects used in the study. AMH levels were significantly higher, which might be due to the aforementioned limitations in this study. There is a need for further experimental studies in which the effects of RFR emitted by cellular phones can be studied.
  • Küçük Resim Yok
    Öğe
    Thrombin activatable fibrinolysis inhibitor Its role in slow coronary flow
    (Urban & Vogel, 2014) Yildirim, M. N.; Selcoki, Y.; Uysal, S.; Nacar, A. B.; Demircelik, B.; Aydin, H. I.; Eryonucu, B.
    The slow coronary flow (SCF) phenomenon is characterized by slow progression of angiographic contrast medium in the coronary arteries in the absence of stenosis in the epicardial vessels. The pathophysiological mechanisms of SCF phenomenon remain uncertain. Several hypotheses, however, have been suggested for SCF phenomenon, including an early form of atherosclerosis, small vessel dysfunction, dilatation of coronary vessels, imbalance between vasoconstrictor and vasodilatory factors, platelet function disorder, and inflammation. Atherosclerosis and inflammation are the most accepted mechanisms for the pathogenesis of SCF. Thrombin activatable fibrinolysis inhibitor (TAFI) was described as a new inhibitor of fibrinolysis recently and plays an important role in coagulation and fibrinolysis. In previous studies, the role of TAFI was associated with inflammation and evolution of atherosclerosis in coronary artery disease. There are no data available about TAFI levels in patients with SCF phenomenon investigated by angiography. Our goal was to evaluate TAFI antigen (Ag) levels in patients with SCF and to determine the association of the TAFI Ag level with traditional cardiovascular risk factors in our study. The study group constituted 41 patients with angiographically confirmed SCF and 46 patients with normal coronary flow as the control group. The TAFI Ag levels of each patient were determined. Between the control and study group, a statistical difference in the levels of TAFI Ag (p < 0.05) was observed. The TAFI Ag level was significantly higher in the SCF group than the control group (132.21 +/- 21.14 versus 122.15 +/- 21.59). We have demonstrated that TAFI might be a risk factor for the development of SCF independently of conventional cardiovascular risk factors. In addition, TAFI Ag levels were positively correlated with C-reactive protein (CRP) known as an acute phase reactant. Our findings support the reports of previous studies that increased TAFI levels may be associated with inflammation. Further large studies are required to evaluate the importance of TAFI antigen levels in relation to the development of SCF.